Literature DB >> 22120983

Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury.

Karim C El Kasmi1, Aimee L Anderson, Michael W Devereaux, Sophie A Fillon, J Kirk Harris, Mark A Lovell, Milton J Finegold, Ronald J Sokol.   

Abstract

UNLABELLED: Infants with intestinal failure who are parenteral nutrition (PN)-dependent may develop cholestatic liver injury and cirrhosis (PN-associated liver injury: PNALI). The pathogenesis of PNALI remains incompletely understood. We hypothesized that intestinal injury with increased intestinal permeability combined with administration of PN promotes lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4) signaling dependent Kupffer cell (KC) activation as an early event in the pathogenesis of PNALI. We developed a mouse model in which intestinal injury and increased permeability were induced by oral treatment for 4 days with dextran sulphate sodium (DSS) followed by continuous infusion of soy lipid-based PN solution through a central venous catheter for 7 (PN7d/DSS) and 28 (PN28d/DSS) days. Purified KCs were probed for transcription of proinflammatory cytokines. PN7d/DSS mice showed increased intestinal permeability and elevated portal vein LPS levels, evidence of hepatocyte injury and cholestasis (serum aspartate aminotransferase, alanine aminotransferase, bile acids, total bilirubin), and increased KC expression of interleukin-6 (Il6), tumor necrosis factor α (Tnfα), and transforming growth factor β (Tgfβ). Markers of liver injury remained elevated in PN28d/DSS mice associated with lobular inflammation, hepatocyte apoptosis, peliosis, and KC hypertrophy and hyperplasia. PN infusion without DSS pretreatment or DSS pretreatment alone did not result in liver injury or KC activation, even though portal vein LPS levels were elevated. Suppression of the intestinal microbiota with broad spectrum antibiotics or ablation of TLR4 signaling in Tlr4 mutant mice resulted in significantly reduced KC activation and markedly attenuated liver injury in PN7d/DSS mice.
CONCLUSION: These data suggest that intestinal-derived LPS activates KC through TLR4 signaling in early stages of PNALI.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22120983      PMCID: PMC4986925          DOI: 10.1002/hep.25500

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

1.  Lack of enteral nutrition--effects on the intestinal immune system.

Authors:  Barbara E Wildhaber; Hua Yang; Ariel U Spencer; Robert A Drongowski; Daniel H Teitelbaum
Journal:  J Surg Res       Date:  2005-01       Impact factor: 2.192

Review 2.  The role of inflammation in cholestasis: clinical and basic aspects.

Authors:  Astrid Kosters; Saul J Karpen
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

3.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

4.  Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth.

Authors:  S N Lichtman; E E Okoruwa; J Keku; J H Schwab; R B Sartor
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 5.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

6.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

Review 7.  Causes and management of intestinal failure in children.

Authors:  Olivier Goulet; Frank Ruemmele
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

8.  Stigmasterol, a soy lipid-derived phytosterol, is an antagonist of the bile acid nuclear receptor FXR.

Authors:  Beth A Carter; Olga A Taylor; Daniel R Prendergast; Tracy L Zimmerman; Richard Von Furstenberg; David D Moore; Saul J Karpen
Journal:  Pediatr Res       Date:  2007-09       Impact factor: 3.756

Review 9.  II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin.

Authors:  R G Thurman
Journal:  Am J Physiol       Date:  1998-10

10.  Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases.

Authors:  Eduardo Zambrano; Magdy El-Hennawy; Richard A Ehrenkranz; Daniel Zelterman; Miguel Reyes-Múgica
Journal:  Pediatr Dev Pathol       Date:  2004-07-30
View more
  55 in total

Review 1.  Hepatobiliary Manifestations of Short Bowel Syndrome and Intestinal Failure-Associated Liver Disease.

Authors:  Jennifer Wang; Dejan Micic
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-05-01

Review 2.  New Insights Into Intestinal Failure-Associated Liver Disease in Children.

Authors:  Racha T Khalaf; Ronald J Sokol
Journal:  Hepatology       Date:  2020-03-18       Impact factor: 17.425

Review 3.  Autologous intestinal reconstruction surgery as part of comprehensive management of intestinal failure.

Authors:  Mikko P Pakarinen
Journal:  Pediatr Surg Int       Date:  2015-03-29       Impact factor: 1.827

Review 4.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

Review 5.  Altered nutrient status reprograms host inflammation and metabolic health via gut microbiota.

Authors:  Rachel M Golonka; Xia Xiao; Ahmed A Abokor; Bina Joe; Matam Vijay-Kumar
Journal:  J Nutr Biochem       Date:  2020-02-22       Impact factor: 6.048

6.  Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.

Authors:  Diptadip Dattaroy; Ratanesh Kumar Seth; Suvarthi Das; Firas Alhasson; Varun Chandrashekaran; Gregory Michelotti; Daping Fan; Mitzi Nagarkatti; Prakash Nagarkatti; Anna Mae Diehl; Saurabh Chatterjee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-30       Impact factor: 4.052

7.  Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2015-06-27       Impact factor: 4.406

8.  Two-Year Neurodevelopment and Growth Outcomes for Preterm Neonates Who Received Low-Dose Intravenous Soybean Oil.

Authors:  Margaret L Ong; Isabell B Purdy; Orly L Levit; Daniel T Robinson; Tristan Grogan; Martiniano Flores; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-19       Impact factor: 4.016

9.  The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome.

Authors:  Shun Onishi; Tatsuru Kaji; Waka Yamada; Kazuhiko Nakame; Tomoe Moriguchi; Koushirou Sugita; Koji Yamada; Takafumi Kawano; Motoi Mukai; Masakazu Souda; Sohsuke Yamada; Takako Yoshioka; Akihide Tanimoto; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2016-09-20       Impact factor: 1.827

Review 10.  Impact of new-generation lipid emulsions on cellular mechanisms of parenteral nutrition-associated liver disease.

Authors:  Douglas G Burrin; Ken Ng; Barbara Stoll; Miguel Sáenz De Pipaón
Journal:  Adv Nutr       Date:  2014-01-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.